ScreenerHero

OPTI Optimi Health Corp.

CNQ · CA · Consumer Defensive · Drug Manufacturers - Specialty & Generic · optimihealth.ca
6.400CAD-2.29%Mkt Cap: 26.69M $P/E: —

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap26.69M USD
Enterprise Value20.91M USD
Revenue (TTM)127.93K USD
Gross Profit-49.62K USD
Net Income (TTM)-2.70M USD
Revenue/Share0.05 CAD
Last Price6.400 CAD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorConsumer Defensive
IndustryDrug Manufacturers - Specialty & Generic
ISINCA68405H1001
Valuation
P/E (Trailing)—
P/E (Forward)-10.00
PEG—
EV/EBITDA-6.83
EV/Revenue163.47
P/S208.60
P/B2.08
EPS (TTM)-2.15
EPS (Forward)-0.64
52W Range
4.65022% of range12.60
52W High12.60 CAD
52W Low4.650 CAD
Profitability
Gross Margin-15.98%
Oper. Margin-957.82%
EBITDA Margin0.00%
Profit Margin-870.75%
ROE-56.49%
ROA-24.40%
Growth
Revenue Growth-28.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.91M USD
CapEx (TTM)64.36K USD
FCF Margin-982.31%
FCF Yield-4.71%
Net Debt-5.77M USD
Net Debt/EBITDA1.88
Balance Sheet
Debt/Equity0.99
Current Ratio1.73
Quick Ratio1.62
Book Value/Sh3.08 CAD
Cash/Share2.28 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateMay 20, 2026
Analyst Consensus
Rating—
Target (Mean)15.00 CAD
Upside (mean)+134.4%
Target Range15.00 CAD – 15.00 CAD
# Analysts1
Ownership
Shares Out.5.73M
Float4.65M
Insiders12.66%
Institutions7.75%
Short Interest
Short Ratio0.2d
Short % Out.0.02%
Shares Short1.11K
Short (prev mo.)17.55K
Technical
SMA 506.711 (-4.6%)
SMA 2008.205 (-22.0%)
Beta1.59
S&P 52W Chg14.58%
Avg Vol (30d)5.57K
Avg Vol (10d)2.80K
Technical Indicators
RSI (14)42.1
MACD-0.0304
MACD Signal0.0064
MACD Hist.-0.0368
BB Upper7.156 CAD
BB Middle6.766 CAD
BB Lower6.375 CAD
BB Width11.53%
ATR (14)0.3187 CAD
Vol Ratio (20d)0.26x